Investment Thesis
Agilent demonstrates solid operational efficiency with a 19.6% operating margin and healthy profitability (17% net margin), supported by consistent revenue growth of 6.7% YoY. The company maintains strong financial health with a 2.07x current ratio, manageable 0.44x debt-to-equity leverage, and excellent 14.1x interest coverage, though ROE of 4.4% suggests capital deployment could be optimized.
A Strengths
- Strong operating margin of 19.6% indicating pricing power and cost discipline in analytical instruments sector
- Solid liquidity position with 2.07x current ratio and $1.8B cash against $5.9B total liabilities
- Consistent profitability growth with 6.7% revenue growth and 1.1% net income growth despite modest EPS expansion of 3.2%
- Healthy free cash flow generation of $175M (9.7% FCF margin) providing capital for investments and shareholder returns
- Conservative leverage with 0.44x debt-to-equity ratio and strong 14.1x interest coverage indicating financial stability
A Risks
- Low return on equity of 4.4% and ROA of 2.4% suggest inefficient capital utilization relative to asset base
- Revenue growth of 6.7% is modest for a specialized analytical instruments company, potentially indicating market maturity or competitive pressures
- Net income growth of only 1.1% significantly lags revenue growth of 6.7%, suggesting margin compression or higher operating costs
- Missing gross margin data limits visibility into product-level profitability and pricing dynamics
- Limited insider activity with only 3 Form 4 filings in 90 days suggests minimal insider confidence signals
Key Metrics to Watch
- Operating margin sustainability as revenue grows
- Return on equity improvement and capital efficiency
- Free cash flow growth rate and cash conversion quality
- Gross margin trends once data becomes available
- Revenue growth acceleration in core analytical instruments markets
A Financial Metrics
Revenue
$1.8B
Net Income
$305.0M
EPS (Diluted)
$1.07
Free Cash Flow
$175.0M
Total Assets
$12.8B
Cash Position
$1.8B
A Profitability Ratios
Gross Margin
N/A
Operating Margin
19.6%
Net Margin
17.0%
ROE
4.4%
ROA
2.4%
FCF Margin
9.7%
A Balance Sheet & Liquidity
Current Ratio
2.07x
Quick Ratio
1.59x
Debt/Equity
0.44x
Debt/Assets
46.1%
Interest Coverage
14.12x
Long-term Debt
$3.1B
Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: Mar 18, 2026 |
Data as of: 2026-01-31 |
Powered by Claude AI